These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 17404719)

  • 61. The spontaneous reporting of adverse drug reactions by nurses.
    Hall M; McCormack P; Arthurs N; Feely J
    Br J Clin Pharmacol; 1995 Aug; 40(2):173-5. PubMed ID: 8562303
    [TBL] [Abstract][Full Text] [Related]  

  • 62. An adverse drug event manager facilitates spontaneous reporting of adverse drug reactions.
    Vinther S; Klarskov P; Borgeskov H; Darsø P; Christophersen AK; Borck B; Christensen C; Hansen MV; Halladin NM; Christensen MB; Harboe KM; Lund M; Jimenez-Solem E
    Dan Med J; 2017 Jan; 64(1):. PubMed ID: 28007050
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Ten years of adverse drug reaction reports for the multiple sclerosis immunomodulatory therapies: a Canadian perspective.
    Tremlett HL; Oger J
    Mult Scler; 2008 Jan; 14(1):94-105. PubMed ID: 17881392
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Adverse drug reaction reporting by community pharmacists-The barriers and facilitators.
    Hughes ML; Weiss M
    Pharmacoepidemiol Drug Saf; 2019 Dec; 28(12):1552-1559. PubMed ID: 31131966
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Knowledge, attitude and practices associated with adverse drug reaction reporting amongst doctors in a teaching hospital.
    Chopra D; Wardhan N; Rehan HS
    Int J Risk Saf Med; 2011; 23(4):227-32. PubMed ID: 22156087
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Texting-Based Reporting of Adverse Drug Reactions to Ensure Patient Safety: A Feasibility Study.
    Vergeire-Dalmacion G; Castillo-Carandang NT; Juban NR; Amarillo ML; Tagle MP; Baja ES
    JMIR Public Health Surveill; 2015; 1(2):e12. PubMed ID: 27227130
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Perception of pharmacovigilance among doctors in a tertiary care hospital: influence of an interventional lecture.
    Sanghavi DR; Dhande PP; Pandit VA
    Int J Risk Saf Med; 2013; 25(4):197-204. PubMed ID: 24305558
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Are consumers ready to take part in the Pharmacovigilance System?--a Portuguese preliminary study concerning ADR reporting.
    Matos C; van Hunsel F; Joaquim J
    Eur J Clin Pharmacol; 2015 Jul; 71(7):883-90. PubMed ID: 26004569
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Adverse drug reactions reporting practice and associated factors among community health extension workers in public health facilities, Southwest, Nigeria.
    Adedeji WA; Adegoke AB; Fehintola FA
    Pan Afr Med J; 2021; 40():165. PubMed ID: 34970407
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Reporting of adverse drug reactions in Iceland in 1999 to 2004].
    Jóhannsson M; Agústsdóttir E
    Laeknabladid; 2006 Apr; 92(4):283-7. PubMed ID: 16582456
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The involvement of nurses in reporting suspected adverse drug reactions: experience with the meningococcal vaccination scheme.
    Ranganathan SS; Houghton JE; Davies DP; Routledge PA
    Br J Clin Pharmacol; 2003 Dec; 56(6):658-63. PubMed ID: 14616426
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Adverse drug reaction reporting by patients in the Netherlands: three years of experience.
    de Langen J; van Hunsel F; Passier A; de Jong-van den Berg L; van Grootheest K
    Drug Saf; 2008; 31(6):515-24. PubMed ID: 18484785
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Hospital pharmacists' knowledge and opinions regarding adverse drug reaction reporting in Northern China.
    Su C; Ji H; Su Y
    Pharmacoepidemiol Drug Saf; 2010 Mar; 19(3):217-22. PubMed ID: 20033911
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Effects of e-mails containing ADR information and a current case report on ADR reporting rate and quality of reports.
    Johansson ML; Brunlöf G; Edward C; Wallerstedt SM
    Eur J Clin Pharmacol; 2009 May; 65(5):511-4. PubMed ID: 19127360
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Knowledge, Attitudes, and Practices of Pharmacovigilance and ADRs Spontaneous Reporting Among Pediatricians and Pediatric Residents in Jordan.
    Mukattash TL; Alwadi MW; Abu-Farha RK; Jarab AS; Al-Zubiedi SA; Alwedyan T
    Curr Clin Pharmacol; 2018; 13(1):45-54. PubMed ID: 29521246
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Patients' experiences on adverse drug reactions reporting: a qualitative study.
    Al Dweik R; Yaya S; Stacey D; Kohen D
    Eur J Clin Pharmacol; 2020 Dec; 76(12):1723-1730. PubMed ID: 32661571
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Influence of pharmacists' attitudes on adverse drug reaction reporting : a case-control study in Portugal.
    Herdeiro MT; Figueiras A; Polónia J; Gestal-Otero JJ
    Drug Saf; 2006; 29(4):331-40. PubMed ID: 16569082
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Underreporting of adverse drug reactions: attitudes of Irish doctors.
    Williams D; Feely J
    Ir J Med Sci; 1999; 168(4):257-61. PubMed ID: 10624366
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Drug-safety reporting in Polish nursing practice-Cross sectional surveys.
    Zimmermann A; Flis A; Gaworska-Krzemińska A; Cohen MN
    PLoS One; 2020; 15(10):e0241377. PubMed ID: 33108377
    [TBL] [Abstract][Full Text] [Related]  

  • 80. A cross-sectional survey of knowledge, attitude, and willingness to engage in spontaneous reporting of adverse drug reactions by Korean consumers.
    Kim S; Yu YM; You M; Jeong KH; Lee E
    BMC Public Health; 2020 Oct; 20(1):1527. PubMed ID: 33032559
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.